A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancer
| Image |  |
|---|---|
| Description | scientific article published in May 2014 |
| Author/s |
author: Judith Stift Michael Gnant Sebastian F Schoppmann Christine Brostjan |
| Publication date | May 1, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |